Pillsbury Winthrop Shaw Pittman LLP advised Invitae Corporation on the deal. Invitae Corporation announced its private placement of $1.15 billion of convertible senior notes to support the...
Invitae Corporation’s $1.15 Billion Notes Private Placement
HYBE’s $1 Billion Acquisition of Ithaca Holdings
Paul Hastings, LLP advised HYBE on the deal. HYBE (formerly Big Hit Entertainment), a South Korean entertainment lifestyle platform company, announced the $1 billion acquisition of Ithaca...
The Topps Company’s $1.3 Billion Business Combination with Mudrick Capital Acquisition Corp.
Paul Hastings LLP advised Jefferies on the deal. Kirkland & Ellis advised The Topps Company, while Weil advised Mudrick Capital Acquisition Corporation II. Jefferies acted as...
Uphold’s Acquisition of JNK Securities
Paul Hastings LLP advised Uphold on the deal. Uphold, a leading digital money platform serving more than five million customers in more than 150 countries, obtained approval...
Hessefort v. Super Micro Computer, Inc.
Robbins Geller Rudman & Dowd LLP, Pomerantz LLP , Jones Day, Paul Hastings LLP, Maxwell Law, PC, Lieff Cabraser Heimann & Bernstein,LLP, Saxena White P.A. and...
Merck’s Acquisition of Alydia Health
Paul Hastings advised Merck on the deal. Merck, known as MSD outside the United States and Canada, announced a definitive agreement with Alydia Health, a commercial-stage medical...
Fibra Uno’s US$300 Million Senior Notes Offering
Paul Hastings LLP and Mijares, Angoitia, Cortés y Fuentes advised Goldman Sachs & Co., Santander and Actinver Securities as initial purchasers on the deal while Holland...
CONREN LAND’s Acquisition of Neuer Hafenklang Property
Paul Hastings LLP advised CONREN LAND on the deal. CONREN LAND announced the acquisition of the Hamburg commercial property “Neuer Hafenklang”. CONREN Land has purchased the commercial...
PE Executives’ Departure from Riverstone Holdings
Paul Hastings, LLP advised Ken Ryan, Alfredo Marti, Chris Hunt and Carl Williams on the deal. Ken Ryan, Alfredo Marti, Chris Hunt and Carl Williams announced...
XOMA and Viracta Therapeutics’ Multi-License Milestone and Royalty Monetization Transaction
Paul Hastings LLP advised Xoma Corporation on the deal. Xoma Corporation, a biotechnology and pharmaceutical royalty aggregator announced its multi-license and milestone monetization transaction with Viracta Therapeutics....
Cheerwin Group’s US$394.5 Million Hong Kong IPO
Paul Hastings, LLP advised the joint sponsors and underwriters on the deal. Cheerwin Group Limited announced its US$394.5 million global offering and listing on the Main Board of...
Fintech Evolution Acquisition Corp.’s $240 million IPO
Paul Hastings, LLP advised UBS as sole book-running manager on the deal. UBS served as sole book-running manager for the $240 million IPO for Fintech Evolution...